Choreo LLC Has $913,000 Stock Holdings in Relx Plc (NYSE:RELX)

Choreo LLC increased its stake in Relx Plc (NYSE:RELX) by 3.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 20,106 shares of the technology company’s stock after acquiring an additional 702 shares during the quarter. Choreo LLC’s holdings in Relx were worth $913,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. FMR LLC lifted its position in shares of Relx by 8.3% in the 3rd quarter. FMR LLC now owns 7,148,837 shares of the technology company’s stock worth $339,284,000 after purchasing an additional 548,423 shares during the period. Mediolanum International Funds Ltd bought a new position in Relx during the third quarter worth $12,902,000. Bank of Montreal Can lifted its holdings in Relx by 194.9% in the third quarter. Bank of Montreal Can now owns 227,211 shares of the technology company’s stock valued at $10,806,000 after buying an additional 150,163 shares during the period. Public Employees Retirement System of Ohio bought a new stake in Relx during the third quarter valued at $6,366,000. Finally, Reynders McVeigh Capital Management LLC grew its holdings in Relx by 31.8% during the 3rd quarter. Reynders McVeigh Capital Management LLC now owns 495,004 shares of the technology company’s stock worth $23,493,000 after acquiring an additional 119,405 shares during the period. 15.02% of the stock is currently owned by institutional investors.

Relx Stock Performance

Shares of NYSE RELX opened at $49.98 on Monday. The firm’s 50-day moving average price is $47.45 and its 200-day moving average price is $46.98. The company has a current ratio of 0.48, a quick ratio of 0.42 and a debt-to-equity ratio of 1.63. Relx Plc has a 1-year low of $40.25 and a 1-year high of $50.84.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on RELX. StockNews.com assumed coverage on Relx in a research note on Wednesday, October 30th. They issued a “hold” rating on the stock. Redburn Atlantic assumed coverage on Relx in a research note on Wednesday, January 8th. They issued a “buy” rating on the stock.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.